Assessing the utility and benefit of granulocyte-colony stimulating factor (G-CSF) in adjuvant therapy for stage III colon cancer.

Vishal Vashistha,Robert Pelley,Marc A. Shapiro,Bassam Estfan

Assessing the utility and benefit of granulocyte-colony stimulating factor (G-CSF) in adjuvant therapy for stage III colon cancer.

2016

Vishal Vashistha
Robert Pelley
Marc A. Shapiro
Bassam Estfan

e15136Background: The role of granulocyte-colony stimulating factor (G-CSF) agents for patients undergoing oxaliplatin-based adjuvant therapy for stage III colon cancer has not been assessed. We so...

Keywords:

Adjuvant therapy
Oncology
Stage III Colon Cancer
Granulocyte colony-stimulating factor
Pathology
Medicine
Internal medicine
Oxaliplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations